News

Scientists identify the segmentation and consolidation mechanism of long-term memories

“Boundary events” delimit and reactivate the memory of the previous sequence of events in order to store it in the long-term memory as discrete episodes Continuous experiences, discrete memories “Boundary events” trigger memory encoding Rapid reactivation of memories leads to long-term memory consolidation.

Leer más about Scientists identify the segmentation and consolidation mechanism of long-term memories

El III Premio Martí Vía para la investigación oncológica recae al Programa ProCURE

Un proyecto de investigación del investigador del Programa ProCURE, David Garcia Molleví, ha recibido la beca Martí Vía, dotada con 30.000 euros

Leer más about El III Premio Martí Vía para la investigación oncológica recae al Programa ProCURE

International collaboration at the ”Amino acid transport defects” symposium

The symposium “Amino acid transport defects”, organized by the Rare Diseases CIBER and the Ramón Areces Foundation, took place on November 20th and 21st at its headquarters in Madrid. In addition to national researchers, including the group of Dr. Virgina Nunes of IDIBELL, who coorganized the symposium, seventeen of the leading specialists in this field […]

Leer más about International collaboration at the ”Amino acid transport defects” symposium

The isoforms of the HP1 protein differentially regulate the organization and structure of heterochromatin

Researchers from the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Àlex Vaquero, have elucidated the role of HP1 proteins in relation to chromatin structure and genome stability, distinguishing different functions based on the presence of different variants of this protein. The work, published in Cell Reports, was […]

Leer más about The isoforms of the HP1 protein differentially regulate the organization and structure of heterochromatin

Best Ideas 2017” award to Manel Esteller

Last Monday, November 13th, the ‘Best Ideas 2017’ awards ceremony, organized annually by the Diario Médico newspaper, took place at the National Theater of Catalonia. In this year’s edition, Dr. Manel Esteller, Researcher of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Research Professor and Professor of Genetics of the University of Barcelona received one of […]

Leer más about Best Ideas 2017” award to Manel Esteller

Ramon Salazar receives funding for a research project on colon cancer

The Spanish Association Against Cancer (AECC) and the Carlos III Health Institute (ISCII) have decided to financially contribute to the ‘Horizon 2020 TRASCAN’ program of the European Union to fund five Spanish projects TRASCAN Project

Leer más about Ramon Salazar receives funding for a research project on colon cancer

The ‘Viladecans Against Cancer’ Association Coordinator raises 16.186 euros for stomach cancer research in IDIBELL

During the course of an open ‘paella’ that brought together seven hundred and fifty people in the Cúbic space of Viladecans, the Association Viladecans Against Cancer officially offered a 16,186 euros check to IDIBELL for the investigation of new therapies in the fight against stomach cancer, led by Dr. Núria Sala (IDIBELL-ICO). This amount brings […]

Leer más about The ‘Viladecans Against Cancer’ Association Coordinator raises 16.186 euros for stomach cancer research in IDIBELL

Researchers prove the effectiveness of a new drug to prevent the onset and the pain of chemotherapy-induced neuropathy

Peripheral neuropathy is a very common side-effect of chemotherapy and may eventually lead to early discontinuation of treatment. Collaboration between research and industry led to the identification and successful testing of a new molecule capable of preventing this neurological complication. This molecule could potentially become the first existing treatment to prevent this frequent adverse effect and improve the quality of life of cancer patients. Article citation

Leer más about Researchers prove the effectiveness of a new drug to prevent the onset and the pain of chemotherapy-induced neuropathy
Scroll to Top